Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06904534

Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate

Comparison of Fetal Cardiac Functions in Pregnant Women Using Nifedipine and Magnesium Sulfate for Tocolysis

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sanliurfa Education and Research Hospital · Other Government
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The potential unexpected effects of nifedipine and MgSO4, the tocolytic agents used for the indication of preterm labor, on fetal heart will be determined. In this study, the fetal echocardiographic findings of nifedipine and MgSO4 will be compared.

Detailed description

This study will include pregnancies at 24-34 weeks of gestation that are using nifedipine and MgSO4 for tocolysis. Fetal echocardiographic findings of these pregnancies will be recorded

Conditions

Timeline

Start date
2025-01-01
Primary completion
2025-06-30
Completion
2025-11-30
First posted
2025-04-01
Last updated
2025-11-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06904534. Inclusion in this directory is not an endorsement.

Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate (NCT06904534) · Clinical Trials Directory